Asklepios Group Reports Stable First Half with Strategic Growth

In the first half of 2025, Asklepios Kliniken GmbH & Co. KGaA showcased stable development amidst challenging conditions. The Group reported consolidated revenues of EUR 3,148.1 million and a net income of EUR 86.3 million, indicating resilience despite economic pressures.

During the period, Asklepios treated over 1.9 million patients, surpassing the previous year's figures. The Group attributes its stability to strategic initiatives aimed at digital infrastructure improvements and enhanced cooperation within its network, which offset rising costs.

CEO Marco Walker emphasized the effectiveness of these efforts, particularly in digitalization and synergy exploitation, while Joachim Gemmel highlighted a patient-focused approach to medicine as key to maintaining high care standards.